The United Kingdom has left the European Union and the transition period ended on 31 December 2020. This article gives a short overview about the current applicable rules.

On 06. January 2021, "COVID-19 Vaccine Moderna" was authorised in the European Union as the second vaccine against SARS-CoV2.

The Federal Office for Safety in Health Care has been informed by the Danish authority that it has been informed by the Danish tissue bank European Sperm Bank (DK257572) that a child has become ill in connection with the donation of the sperm donor 25231-RUNE.

Based on the recommendation by the European Medicines Agency (EMA), the European Commission issued the marketing authorisation for the COVID-19 vaccine Comirnaty (BioNTech).

In Austria, adverse reactions can be voluntarily reported directly to the Federal Office for Safety in Health Care (BASG) by patients as well as their relatives.

Recall due to potential microbiological contamination.

Due to current events, FAQ No. 2 on accessible information for use has been revised, to better reflect the current approach.

Recall due to unidentified impurities.

In order to monitor the advertising regulations according to the regulations of the Austrian Medicines Act, advertising is always checked to ensure that it complies with the legal requirements.

An update on CCP (COVID-19 Convalescent Plasma) has been forwarded by the European Commission to the Federal Office for Safety in Health Care.